Varun Goel

Dr. Varun Goel earned his post – graduation from Maulana Azad Medical College, Delhi. He completed his DNB (Medical Oncology) from Rajiv Gandhi Cancer Institute and Research Centre, Delhi. Dr. Goel carries a rich experience in the management of both hematological & non hematological malignancies (breast, lung and other solid tumors), as well as Bone Marrow Transplantation. He has cleared “European Certified Medical Oncologist” exam conducted by ESMO. and also MRCP- UK – Certification examination of Medical Oncology. Dr. Goel has keen interest in clinical research & research ethics. He has many publications to his credit published in various National and International peer reviewed journals. He is an active member of a number of professional bodies & societies including European Society for Medical Oncology (ESMO), Indian Cooperative Oncology Network (ICON), Indian Society of Medical and Pediatric Oncology (ISMPO). He has done many oral and poster presentations in national and international conferences. Dr. Goel also has a keen interest in the importance of excellent communication skills on the quality and outcomes of patients. His expertise spans in all types of chemotherapy, intensive protocols, immunotherapy, hormonal therapy in addition to dealing with oncological emergencies, including medical care of patients. He holds deep interest in breast cancer, lung cancer, gastro – intestinal cancer, gynaecological cancer and lymphoma / leukemia / myeloma. Area of Interest: Hematological & Non hematological malignancies (breast, lung and other solid tumors). With extensive training and a solid background in medical oncology, I bring forth a dedication to advancing cancer treatment and patient care. My unique perspective, gained through rigorous hands-on experience as a senior consultant, has equipped me with the skills needed to tackle complex medical challenges effectively. I am passionate about leveraging innovative therapies and evidence-based practices to improve survival rates and enhance the quality of life for oncology patients.

• PUBLICATIONS IN VARIOUS NATIONAL AND INTERNATIONAL JOURNALS
• 1. Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol. 2010;31(2):82-86.
• 2. Goel V, Bose PD, Sarma MP, Hazam RK, Das BC, Gondal R, Kar P. Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(t)ide analogues. Indian J Med Res. 2013;137(6):1208-1209.
• 3. Goel V, Raina S, Chandragouda D, Singh S, Talwar V, Patnaik N. Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas. Int J Trichology. 2014;6(1):23-24.
• 4. Dodagoudar C, Mahanta A, Goswami V, Goel V, Doval DC, Talwar V, Batra U, Singh S, Chauhan D. Efficacy and toxicity of FOLFOX-4 as a second-line chemotherapy in locally advanced unresectable and metastatic carcinoma gall bladder: a prospective observational study. American Society of Clinical Oncology; 2014.
• 5. Upadhyay A, Goel V, Batra U, Goyal P, Dutta K, Aggarwal M, Doval DC. Two cases of ovarian carcinoma with endobronchial metastases: rare presentation. South Asian J Cancer. 2015;4(3):149.
• 6. Goel V, Dgouda C, Singh S, Raina S, Talwar V, Patnaik N, Pasricha S. Small cell carcinoma of the ovary of hypercalcemic type: a rare tumor.
• 7. Goel V, Talwar V, Dodagoudar C, Singh S, Sharma A, Patnaik N. Primary renal primitive neuroectodermal tumor: a rare presentation. J Postgrad Med. 2015;61(2):126-128.
• 8. Singh S, Mishra A, Goel V, Talwar V, Raina S, Dodagoudar C, Mitra S, Saxena U, Shekhon R, Rawal S. Neo-adjuvant chemotherapy followed by surgery vs definitive chemo radiation as treatment for localized carcinoma cervix. European J Cancer. 2015;51:S539-S540.
• 9. John MC, Goel V, Tiwari S, Talwar V, Patnaik N. Case report: non-small cell lung carcinoma presenting as a foot swelling. Lung India. 2015;32(3):292-293.
• 10. Singh S, Mishra A, Goel V, Talwar V, Raina S, Dodagoudar C, Mitra S, Saxena U, Shekhon R, Rawal S. 2727 Neo-adjuvant chemotherapy followed by surgery vs definitive chemo radiation as treatment for localized carcinoma cervix. Eur J Cancer. 2015;51:S539-S540.
• 11. Tiwari S, Goel V, John MC, Patnaik N, Doval DC. Efficacy and toxicity of cetuximab with chemotherapy in recurrent and metastatic head and neck cancer: A prospective observational study. Indian J Cancer. 2016;53(4):487-492.
• 12. Goel V, Dash P, Talwar V, Singh S, Doval DC, Patnaik N. Efficacy and safety of adjuvant intraperitoneal chemotherapy in carcinoma ovary: a prospective observational study. American Society of Clinical Oncology; 2016.
• 13. Manana SS, Goel V, Talwar V, Raina S. NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-FU based combinations in advanced gall bladder cancer patients. Ann Oncol. 2016;27:vi236.
• 14. Dodagoudar C, Doval DC, Mahanta A, Goel V, Upadhyay A, Goyal P, Talwar V, Singh S, John MC, Tiwari S, et al. FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Jpn J Clin Oncol. 2016;46(1):57-62.
• 15. Goel V, Singh S, Talwar V, Goyal P, Upadhyay A, et al. Study of efficacy and safety of adjuvant intraperitoneal chemotherapy in carcinoma ovary. Asian J Oncol. 2016;2(S01):056.
• 16. Dash P, Goel V, Talwar V, Doval DC, Raina S, Goyal P, Upadhyay A, Patnaik N. Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian J Cancer. 2016;53(4):607-611.
• 17. Goel V, Talwar V, Singh S, Doval DC, Patnaik N. Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. Pancreatology. 2016;16(1):S9.
• 18. Goel V, Talwar V, Patnaik N, Raina S, Singh S. 241P NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-fluorouracil (5-FU) based combinations in advanced gallbladder cancer patients. Ann Oncol. 2016;27:ix75-ix76.
• 19. Talwar V, Goel V, Raina S, Talwar V, Patnaik N, Doval DC. Dengue fever in cancer patients: retrospective analysis. Curr Med Res Pract. 2016;6(4):157-159.
• 20. Talwar V, Goel V, Raina S, Patnaik N, Doval DC. Altretamine in advanced pretreated epithelial ovarian carcinoma patients: experience from a center in north India. Curr Med Res Pract. 2016;6(3):109-112.
• 21. Talwar W, Rajpurohit S, Goel V, Raina S, Chandragouda D. Gemcitabine and carboplatin combination chemotherapy in treatment naive patients with inoperable gall bladder cancer. Eur J Cancer. 2016;54:S9.
• 22. Singh S, Goel V, Talwar V, Raina S, Mitra S, Saxena U, Shekhon R, Rawal S. Neo-adjuvant chemotherapy followed by surgery versus definitive chemo radiation as treatment for localized carcinoma cervix. Asian J Oncol. 2016;2(S01):022.
• 23. Talwar V, Raina S, Goel V, Doval DC. Gemcitabine and cisplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer: a study from Northern India cancer institute. Int J Hepatobiliary Pancreat Dis. 2016;6:108-113.
• 24. Prashant V, Singh S, Talwar V, Goyal P, Upadhyay A. Ovary: oral abstract. Asian J Oncol. 2016;2:1.
• 25. Talwar V, Raina S, Goel V, Doval DC. Gemcitabine and carboplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer—A study from Northern Indian Cancer Institute. Br J Med Med Res. 2017;19(12):1-7.
• 26. Raina S, Goel V, Talwar V, et al. Soft palate metastasis: a rare site of metastasis in TCC of urinary bladder. JMS SKIMS. 2017;20(1):47-48.
• 27. Goel V, Jain A, Tiwari S, John MC, Talwar V, Dash P, et al. Randomised prospective study of maintenance tamoxifen versus post adjuvant chemotherapy surveillance only in advanced ovarian cancer patients. Ann Oncol. 2017;28:v339.
• 28. Venkata PPB, Talwar V, Goel V, Prasantha K, Bajaj R, Sharma M, Medisetty P, Ram D, Agrawal C, et al. Unusual tree bark-like skin pigmentation over veins after 5-fluorouracil infusion with spontaneous resolution. Human Journals. 2017;7(3).
• 29. Jajodia A, Koyyala VPB, Goel V, Dash PK, Rajappa SK, Amrith BP. Pancreatic giant cell tumor: a variant of pancreatic adenocarcinoma with aggressive course. Asian J Oncol. 2018;4:79-80.
• 30. Goel V, Tiwari S, Talwar V, Patnaik N, Dash P, Raina S, John MC. 56P plasma circulating ctDNA: potential biomarker in non-small cell lung carcinoma and clinical significance. J Thorac Oncol. 2018;13(4):S29.
• 31. Venkata PPB, Talwar V, Raina S, Goel V, Dash PK, Bajaj R, Sharma M, Medisetty P, Ram D, Agrawal C, et al. Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: a study from North India Cancer Centre. Indian J Cancer. 2018;55(3):222-225.
• 32. Talwar V, Bothra SJ, Goel V, Dash PK, Jajodia A, Domadia K, Choudhary K, Koyyala VPB. Real world outcomes of checkpoint inhibitors immunotherapy in renal and urothelial cancers in a tertiary care cancer center in India. Int J Mol Immuno Oncol. 2019;4(3):63-66.
• 33. Talwar V, Goel V, Dash P. Cancer-related fatigue in carcinoma urinary bladder patients receiving chemotherapy: a single institutional study from northern India. American Society of Clinical Oncology; 2019.
• 34. Dash PK, Koyyala VPB, Suryavanshi M, Jajodia A, Pasricha S, Goel V, Bothra SJ, Goyal S, Batra U, Doval DC. Adoption of molecular testing in breast cancer in a tertiary care center in a developing country. Ann Oncol. 2019;30:ix127.
• 35. Goswami V, Koyyala VPB, Goyal S, Sharma M, Goel V, Dhamne N, Maheshwari U, Sharma A. Efficacy of PARP inhibitors in the treatment of ovarian cancer: a literature-based review. Asian J Oncol. 2019;5(1):1-18.
• 36. Agrawal CR, Sharma M, Talwar V, Goel V, Singh AP. Isolated splenic recurrence of treated jejunal cancer: a case report with brief review of literature. Indian J Med Paediatr Oncol. 2019;40(S01):S163-S165.
• 37. Amrith BP, Koyyala VPB, Dash PK, Goel V, Bansal D, Talwar V. A rare cause of headache in common cancer: ovarian carcinoma with brain metastasis. Indian J Gynecol Oncol. 2019;17:1-4.
• 38. Talwar V, Raina S, Goel V, Dash P, Doval DC. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer. Indian J Med Res. 2020;152(5):475-481.
• 39. Chaudhari KA, Talwar V, Goel V, Dash PK, Bothra S, Domadia K, Koyyala VPB. A rare malignancy at the gastrojejunostomy stump. Cancer Res Stat Treat. 2020;3(2):312-316.
• 40. Goyal P, Maheshwari U, Jain P, Agrawal C, Chaudhari KA, Goyal S, Batra U, Bothra S, Goel V, Talwar V, et al. Rectal cancer in young patients: clinicoepidemiologic profile and treatment outcomes. American Society of Clinical Oncology; 2020.
• 41. Koyyala VPB, Jajodia A, Beer L, Doval DC, Talwar V, Goel V, Batra U, Goyal S, Gupta A, Chaturvedi A, et al. 215P analysis of spatial heterogeneity of responses in metastatic sites with nivolumab in renal cell carcinoma. Ann Oncol. 2020;31:S1324.
• 42. Basnet B, Goyal P, Mahawar V, Bothra SJ, Agrawal C, Thapa BB, Talwar V, Jain P, Koyyala VPB, Goel V, et al. Role of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in the evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer. Indian J Nucl Med. 2020;35(2):105-109.
• 43. Koyyala VPB, Goyal S, Jajodia A, Goel V, Amrith BP, Soni S, Doval DC. Miliary brain metastasis—a rare pattern of metastases from breast cancer. South Asian J Cancer. 2020;9(03):188-189.
• 44. Sharma M, Talwar V, Maheshwari U, Koyyala VPB, Goel V, Dash PK, Batra U, Bajaj R, Yadav A, et al. Role of maintenance gemcitabine in advanced carcinoma gallbladder. South Asian J Cancer. 2020;9(04):204-208.
• 45. Maheshwari U, Rajappa SK, Talwar V, Goel V, Dash PK, Sharma M, et al. Adjuvant chemotherapy in uterine carcinosarcoma: comparison of a doublet and a triplet chemotherapeutic regimen. Indian J Cancer. 2021;58(2):179-184.
• 46. Goyal P, Doval DC, Agarwal C, Jain P, Chaudhari K, Domadia K, Redhu P, Koyyala VPB, Goel V, Batra U, et al. Current treatment approaches for human epidermal growth factor receptor 2-positive breast cancer in adjuvant and neoadjuvant settings. Indian J Med Paediatr Oncol. 2021;42(01):35-45.
• 47. Goel V, Jain P, Goyal P, Patnaik N, Pasricha S, Koyyala V, Talwar V. P-48 Study of paclitaxel and ramucirumab as second-line therapy after failure of FOLFOX-6 regimen in metastatic stomach carcinoma patients. Ann Oncol. 2021;32:S112.
• 48. Goel V, Patnaik N, Talwar V, Chaudhari K, Koyyala V, Goyal P. P-194 Study of efficacy and safety of combination of octreotide acetate LAR with lenvatinib as second-line therapy in patients with advanced G1-G2 NETs of non-pancreatic origin. Ann Oncol. 2021;32:S166.
• 49. Goel V, Patnaik N, Koyyala VPB, Talwar V, Chowdhary K, Jain P, Goyal P, Raina S. 1447P efficacy and toxicity profile of trans dermal buprenorphine for cancer pain management: experience from a tertiary care center in northern India. Ann Oncol. 2021;32:S1078.
• 50. Talwar V, Patnaik N, Goyal P, Doval DC, Goel V. Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. Eur J Mol Clin Med. 2021;8(4):949-958.
• 51. Koyyala VPB, Kulkarni PS, Goel V, Goteti SC, Purohit SR, Jajodia A, et al. 67P Challenges to molecular testing for selecting targeted therapies for oncology patients in India. Ann Oncol. 2021;32:S1366.
• 52. Koyyala VPB, Sharma M, Goyal P, Goel V, Bommera S, Agrawal M, et al. Epidemiological, clinical profile, and treatment outcome of stage IV nonsquamous nonsmall cell lung cancer patients presenting to tertiary care hospital in North India. Oncol J India. 2021;5(3):104-110.
• 53. Koyyala VPB, Chandra S, Goel V, Pasricha S, Gupta M, Muppalla BS, et al. 769P Need for awareness about immune-related adverse events (irAEs) among community physicians in India. Ann Oncol. 2021;32:S1405.
• 54. Joga S, Bansal A, Talwar V, Bothra SJ, Dash P, Goel V, Koyyala VPB. Spontaneous pulmonary arterial embolization: a rare complication of the silicon-based peripherally inserted central venous catheter (PICC). J Vasc Access. 2022;23(3):471-473.
• 55. Dogra A, Talwar V, Goel V, Sekhon R, Rawal S. First-line chemotherapy analysis on survival in carcinoma ovary patients: data from a North Indian cancer center. J Cancer Res Ther. 2022;18(6):1589-1596.
• 56. Domadia K, Goel V, Koyyala VPB, Patnaik N, Chaudhari K, Raina S, Doval DC, Talwar V. Study of gemcitabine plus nab-paclitaxel-based chemotherapy regimen as first-line treatment in metastatic pancreatic carcinoma. South Asian J Cancer. 2022;11(01):031-035.
• 57. Jajodia A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola M. Combined diagnostic accuracy of diffusion and perfusion MR imaging to differentiate radiation-induced necrosis from recurrence in glioblastoma. Diagnostics. 2022;12(3):718.
• 58. Agarwal H, Talwar V, Anand S, Goel V, Patnaik N. Psychological challenges encountered by health care professionals having a risk of accidental exposure and its impact on their wellbeing in a non-Covid hospital during the prevailing pandemic. Int J Health Sci. 2022;5(S3):816-822.
• 59. Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, et al. Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World J Clin Oncol. 2022;13(5):339-351.
• 60. Maheshwari U, Sharma M, Goel V, Goyal P, Jain P, Agrawal C, et al. Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian J Oncol. 2022;8(03):111-118.
• 61. Casolino R, Braconi C, Prete MG, Romero FG, Castro RE, Banales JM, et al. Bridging the equity gap in patient education: the biliary tract cancer BABEL project. Lancet Oncol. 2022;23(5):568-570.
• 62. Jajodia A, Goel V, Patnaik N, Pasricha S, Gupta G, Batra U, Talwar V. Analysis of spatial heterogeneity of responses in metastatic sites in renal cell carcinoma patients treated with nivolumab. Tomography. 2022;8:1363-1373.
• 63. Patnaik N, Pasricha S, Gupta G, Durga G, Sharma SK, Sharma A, et al. EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn’s disease treated with immunomodulator. Indian J Pathol Microbiol. 2022;65(3):739-741.
• 64. Narayan S, Talwar V, Redhu P, Goel V, Jain A, Soni S, et al. Serpentine supra-venous hyperpigmentation “Badge of Courage” in fight against cancer: a brief review. Gulf J Oncol. 2022;1(40):83-87.
• 65. Amrith BP, Goel V, Joga S, Koyyala VPB, Goyal S, Batra U, Doval DC, Talwar V. 122P Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: a prospective observational study. Ann Oncol. 2022;33:S1480.
• 66. Jajodia A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola M. Combined diagnostic accuracy of diffusion and perfusion MR imaging to differentiate radiation-induced necrosis from recurrence in glioblastoma. Diagnostics. 2022;12:718.
• 67. Aggarwal A, Goel S, Sayed AI, Goel V, Talwar V, Singh S. Interaortocaval lymph node metastasis in gall bladder cancer: is it regional node or metastatic disease? J Gastrointest Cancer. 2023;54(4):1252-1260.
• 68. Maheshwari U, Goyal P, Goel V, Patnaik N, Koyyala VPB, Chaudhari K, et al. Study of efficacy and toxicity of capecitabine maintenance after response to docetaxel, cisplatin, and 5-fluracil-based chemotherapy in advanced carcinoma stomach. Gulf J Oncol. 2023;42(42):40-46.
• 69. Goyal P, Joga S, Tripathi R, Jain A, Sharma M, Goel V, et al. Real world experience with osteosarcoma from a tertiary cancer centre in India. J Cancer Sci Clin Ther. 2023;7(2):93-99.
• 70. Chaudhari V, Ramaswamy A, Srinivas S, Agarwal A, Seshadri RA, Talwar V, et al. Practice patterns and survival in patients with resected pancreatic ductal adenocarcinomas (PDAC)—results from the multicentre Indian pancreatic & periampullary adenocarcinoma project (MIPPAP) study. J Gastrointest Cancer. 2023;54(4):1338-1346.
• 71. Mitra S, Simson DK, Gehani M, Barik S, Khurana R, Singh S, et al. Survival and recurrence patterns in patients with stomach adenocarcinoma receiving chemotherapy or chemoradiotherapy after D2 gastrectomy in a tertiary care cancer institute: a retrospective real-world evidence cohort study. Adv Radiat Oncol. 2023;8(6):101280.
• 72. Soni S, Jain A, Goyal V, Narayan S, Redhu P, Goyal P, Swamy S, Talwar V. Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma—a single-center experience in India. Ann Pancreatic Cancer. 2023;6:9.
• 73. Goyal V, Jain A, Basu D, Soni S, Talwar V. Unveiling the uncommon: disseminated intravascular coagulation as an unusual presentation of metastatic carcinoma prostate. IP Arch Cytol Histopathol Res. 2023;8(2):119-122.
• 74. Goyal P, Jain P, Agrawal C, Jain SB, Talwar V, Batra U, et al. Breast cancer in transgenders: narrative review. Indian J Med Paediatr Oncol. 2024;45(01):003-008.
• 75. Saha S, Goel V, Chakraborty A, Talwar V. Synchronous triple malignancy of esophagus, pancreas, and pyriform sinus: a prima facie report. Indian J Surg Oncol. 2024;15(Suppl 2):349-354.
• 76. Jain A, Goyal V, Soni S, Narayan S, Redhu P, Shivaraudaiah SS, Talwar V. Hair depigmentation in a patient treated with pazopanib: a case report and a comprehensive analysis. Indian J Skin Allergy. 2024;1:3-13.
• 77. Goyal P, Mukherjee A, Tripathi R, Doval DC, Talwar V, Goyal S, et al. Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer from India. American Society of Clinical Oncology; 2024.
• 78. Goyal P, Doval DC, Jain S, Talwar V, Goyal S, Batra U, et al. Survival and safety analysis of eribulin in Indian patients with metastatic breast cancer: a real world clinical experience. American Society of Clinical Oncology; 2024.
• 79. Jain A, Soni S, Goyal V, Narayan S, Redhu P, Basu DA, et al. Cardiac metastases: an unusual site for colon cancer metastases. Int J Clin Stud Med Case Rep. 2024;41(4):002.
• 80. Gupta M, Singh S, Talwar V, Goyal S, Batra U, Goel S, et al. 430P Is Ga68-FAPI PET-CT a new imaging standard in poorly cohesive carcinoma stomach? An initial experience in comparison to FDG PET-CT. Ann Oncol. 2024;35:S174.
• 81. Jain A, Goyal V, Soni S, Narayan S, Redhu P, Shivaraudaiah SS, et al. 261P Evaluating tumor regression grade in locally advanced rectal cancer: identifying predictive factors and clinical implications following neoadjuvant chemoradiotherapy. Ann Oncol. 2024;35:S111.
• 82. Jain A, Soni S, Domadia KR, Goyal V, Goyal P, Narayan S, et al. 345P Match-pair analysis of mFOLFIRINOX vs gemcitabine+ nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: survival and toxicity outcomes. Ann Oncol. 2024;35:S143-S144.
• 83. Jain A, Goel V, Soni S, Narayan S, Redhu P, Basu DA, et al. Targeted precision: antibody-drug conjugates revolutionize urothelial carcinoma therapy. Curr Trends Intern Med. 2024;8(233):1-15.
• 84. Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, et al. Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients—a match-pair analysis from a multi-institutional cohort study (The MIPPAP study). HPB. 2024.
• 85. Gupta M, Singh S, Talwar V, Goyal S, Batra U, Goel S, et al. Diagnostic performance of Ga68-FAPI in signet ring cell carcinoma stomach in comparison to FDG: an initial experience. Society of Nuclear Medicine; 2024.
• 86. Patel AB, Goel V, Joga S, Koyyala VPB, Goyal S, Doval DC, et al. Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: a prospective observational study. South Asian J Cancer. 2024.
• 87. Mahajan S, Simson DK, Antony V, Pahuja A, Pansuriya M, Goel S, et al. 100P Treatment outcomes in rectal cancer with radiological positive circumferential resection margin treated with short course radiation therapy. Ann Oncol. 2024;35:S1441.
• 88. Patnaik N, Duggal R, Dua A, Singh J, Mane PS, Saxena S, Goel V. 434P: clinicopathological characteristics and aggressive behavior of SMARCA4-deficient undifferentiated thoracic tumors mimicking NSCLC: data from a tertiary cancer center in India. J Thorac Oncol. 2025;20(3):S251.
• 89. Chowdhury S, Aggarwal A, Goel S, Goel V, Talwar V, Singh S. Gastric cancer with limited peritoneal metastasis: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Indian J Gastroenterol. 2025;1-8.
• 90. Patel, Amrith B, Goel, Varun, Joga, Srujana, Koyyalaa, V.P.B, Goyal, Sumit, Doval, Dinesh C, Batra, Ullas, Talwar, Vineet, . Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: A
  prospective observational study. South Asian J Cancer. 025;14(2):271-276.
• 91. Goel, Varun, Jain, Arpit, Basu, A Dharmishtha, Jaju, Akanksha, Patnaik, Nivedita, Talwar, Vineet, Rawal, Sudhir, . A Comparative Study of Gemcitabine-Cisplatin vs. Dose-Dense MVAC (Methotrexate, Vinblastine, Doxorubicin, and Cisplatin) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Single-Institution experience. cureus. 025;17(5):e85071.
• 92. Goel, Varun, Jain, Arpit, Basu, Dharmishtha, Patnaik, Nivedita, Talwar, Vineet, Swamy, Sidhant, Rawal, Sudhir, . Comparative Efficacy and Toxicity of Gemcitabine-Cisplatin vs. Gemcitabine- Carboplatin in Metastatic Carcinoma of the Urinary Bladder: A Retrospective Review. Gulf Journal of
  Oncology. 2025;48:60-6.
• 93. Jain, Arpit, Goel, Varun, Soni, Satyajeet, Patnaik, Nivedita, Jaju, Akanksha, Goel, Shaifali, Basu A, Dharmistha, Talwar, Vineet, Singh, Shivender, . Comparative Efficacy and Toxicity of Modified FOLFIRINOX and Gemcitabine Plus Nab-Paclitaxel in
  Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Retrospective Analysis. Cureus. 2025;17(7):e87389.
• 94. Talwar, V, Goel, V, Jain, A, Basu, D, . To be or not to be: Weight loss and gastrointestinal symptoms as cardinal markers of malnutrition in gastrointestinal (GI) cancer patients. Clinical Nutrition ESPEN. 2025;69:882.
• 95. Sethi, JS, Simson, DK, Mahajan, S, Anthony, V, Prakash, K, Mehto, S, Talwar, V, Goyal, S, Goel, V, Goel, S, . Short-Course Radiotherapy, Chemotherapy and Surgery in Rectal Cancer
  Patients under 50: Recurrence and Survival Outcomes. International Journal of Radiation Oncology, Biology, Physics. 2025;123(1):e696-e697.
• 96. Jain, Arpit, Goel, Varun, Jaju, Akanksha, Patnaik, Nivedita, Karsanbhai, V Krunal, Talwar, Vineet, . Between a rock and a hard place: Papillary renal cell carcinoma with synchronous lung
  adenocarcinoma. Onco Critical Care. 2025;3(2):74- 7.
• 97. Goel, Varun, Jain, Arpit, Patnaik, Nivedita, Basu, Dharmistha, Goel, Shaifali, Jaju, Akanksha, Talwar, Vineet, Singh, Shivendra, . Efficacy and Safety of Paclitaxel Plus Ramucirumab as Second-Line Therapy in Advanced Gastric Cancer: A Retro- Prospective Single-Centre Study. Gulf Journal of Oncology. 2025:75-79.
• 98. Goel, Varun, Basu, Dharmistha, Jain, Arpit, Patnaik, Nivedita, Jaju, Akanksha, Mehta, Anurag, Talwar, Vineet, . Clinical Implications of Dihydropyrimidine Dehydrogenase Deficiency in
  Gastrointestinal and Hepatopancreaticobiliary Cancers Treated with Fluoropyrimidines: A Prospective Observational Study. JCO Glob Oncol. 2025;11:e2500442.
• 99. Dewan, Abhinav, Talwar, Vineet, Goel, Varun, Choudhary, K Sabeena, Mehrotra, Krati, Chugh, Swati, Saha, Sekhar, Basu, A Dharmishta, Mukherjee, Anindya, Bansal, Rashmi, Jain, Arpit, .
  Clinical Efficacy and Safety of Gemcitabine– Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North India. Journal of Gastrointestinal Cancer. 2025;56(233).
• 100. Jain, A, Goel, V, Basu, DA, Goyal, J, Talwar, V, . 72P Eye to AI: AI-powered assessment of radiological-pathological concordance and prognostication in rectal cancer patients treated with neoadjuvant SCRT. ESMO Real World Data and Digital Oncology. 2025;10.
• 101. Jain, A, Goel, V, Goyal, J, Soni, S, Basu, DA, Shivarudraiah, SS Mathighatta, Goyal, P, Talwar, V, . 127P AI-powered assessment of pancreatic cancer resectability: A comparative study of chatbot models versus NCCN criteria and radiology reports. ESMO Real World Data and Digital Oncology. 2025;10.
• 102. Goel, Varun, Basu, Dharmistha, Jain, Arpit, Patnaik, Nivedita, Jaju, Akanksha's, Talwar, Vineet, . Non-gestational choriocarcinomas in postmenopausal period. BMJ Case Reports. 2025;18(12):e268341.
• 103. Gupta, Manoj, Singh, Shivendera, Talwar, Vineet, Goyal, Sumit, Goel, Shaifali, Goel, Varun, Choudhury, Partha, . A single center prospective study to evaluate effectiveness of 68Ga-FAPI
  PET/CT in the initial evaluation of signet ring cell carcinoma of the stomach.. . 2026.
• 104. Talwar, Vineet, Dogra, Atika, Goel, Varun, Krishna, Vidya, . Survival analysis of second-line chemotherapy in platinum- sensitive relapsed ovarian cancer patients. THE NATIONAL MEDICAL JOURNAL OF INDIA. 2026;39(1):6-12.
• 105. Singh, Shivender, Lahiri, Anupam, Chowdhury, Suchita, Goel, Shaifali, Assif, Syed Iqbal, Aggarwal, Abhishek, Garg, Prerna, Goel, Varun, Talwar, Vineet, Sethi, Jaskaran, . Neoadjuvant Therapy in Gall Bladder Cancer improves Resectability and Survival : A Prospective Study. HPB. 2026;28(1).

• National Academy of Medical Sciences (NAMS)
• European Society of Medical Oncology (ESMO)
• American Society Of Clinical Oncology (ASCO)
• Life Member India Society of Medical and Pediatric Oncology (ISMPO)
• Life Member Indian Cooperative Oncology Network (ICON) Group
• Active member of Delhi Medical Association (DMA)
• Fellow of the Indian Medical Association (IMA)

• Date of Birth: January 1, 1982
• Gender: Male
• Nationality: Indian

• Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol. 2010;31(2):82-86.
• Goel V, Bose PD, Sarma MP, Hazam RK, Das BC, Gondal R, Kar P. Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(t)ide analogues. Indian J Med Res. 2013;137(6):1208-1209.
• Goel V, Raina S, Chandragouda D, Singh S, Talwar V, Patnaik N. Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas. Int J Trichology. 2014;6(1):23-24.
• Dodagoudar C, Mahanta A, Goswami V, Goel V, Doval DC, Talwar V, Batra U, Singh S, Chauhan D. Efficacy and toxicity of FOLFOX-4 as a second-line chemotherapy in locally advanced unresectable and metastatic carcinoma gall bladder: a prospective observational study. American Society of Clinical Oncology; 2014.
• Upadhyay A, Goel V, Batra U, Goyal P, Dutta K, Aggarwal M, Doval DC. Two cases of ovarian carcinoma with endobronchial metastases: rare presentation. South Asian J Cancer. 2015;4(3):149.
• Goel V, Dgouda C, Singh S, Raina S, Talwar V, Patnaik N, Pasricha S. Small cell carcinoma of the ovary of hypercalcemic type: a rare tumor.
• Goel V, Talwar V, Dodagoudar C, Singh S, Sharma A, Patnaik N. Primary renal primitive neuroectodermal tumor: a rare presentation. J Postgrad Med. 2015;61(2):126-128.
• Singh S, Mishra A, Goel V, Talwar V, Raina S, Dodagaudar C, Mitra S, Saxena U, Shekhon R, Rawal S. Neo-adjuvant chemotherapy followed by surgery vs definitive chemo radiation as treatment for localized carcinoma cervix. European J Cancer. 2015;51:S539-S540.
• John MC, Goel V, Tiwari S, Talwar V, Patnaik N. Case report: non-small-cell lung carcinoma presenting as a foot swelling. Lung India. 2015;32(3):292-293.
• Singh S, Mishra A, Goel V, Talwar V, Raina S, Dodagaudar C, Mitra S, Saxena U, Shekhon R, Rawal S. 2727 Neo-adjuvant chemotherapy followed by surgery vs definitive chemo radiation as treatment for localized carcinoma cervix. Eur J Cancer. 2015;51:S539-S540.
• Tiwari S, Goel V, John MC, Patnaik N, Doval DC. Efficacy and toxicity of cetuximab with chemotherapy in recurrent and metastatic head and neck cancer: A prospective observational study. Indian J Cancer. 2016;53(4):487-492.
• Goel V, Dash P, Talwar V, Singh S, Doval DC, Patnaik N. Efficacy and safety of adjuvant intraperitoneal chemotherapy in carcinoma ovary: a prospective observational study. American Society of Clinical Oncology; 2016.
• Manana SS, Goel V, Talwar V, Raina S. NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-FU based combinations in advanced gall bladder cancer patients. Ann Oncol. 2016;27:vi236.
• Dodagoudar C, Doval DC, Mahanta A, Goel V, Upadhyay A, Goyal P, Talwar V, Singh S, John MC, Tiwari S, et al. FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Jpn J Clin Oncol. 2016;46(1):57-62.
• Goel V, Singh S, Talwar V, Goyal P, Upadhyay A, et al. Study of efficacy and safety of adjuvant intraperitoneal chemotherapy in carcinoma ovary. Asian J Oncol. 2016;2(S01):056.
• Dash P, Goel V, Talwar V, Doval DC, Raina S, Goyal P, Upadhyay A, Patnaik N. Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian J Cancer. 2016;53(4):607-611.
• Goel V, Talwar V, Singh S, Doval DC, Patnaik N. Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. Pancreatology. 2016;16(1):S9.
• Goel V, Talwar V, Patnaik N, Raina S, Singh S. 241P NAB-paclitaxel as third-line therapy after failure of gemcitabine and 5-fluorouracil (5-FU) based combinations in advanced gallbladder cancer patients. Ann Oncol. 2016;27:ix75-ix76.
• Talwar V, Goel V, Raina S, Talwar J, Patnaik N, Doval DC. Dengue fever in cancer patients: retrospective analysis. Curr Med Res Pract. 2016;6(4):157-159.
• Talwar V, Goel V, Raina S, Patnaik N, Doval DC. Altretamine in advanced pretreated epithelial ovarian carcinoma patients: experience from a center in north India. Curr Med Res Pract. 2016;6(3):109-112.
• Talwar V, Rajpurohit S, Goel V, Raina S, Chandragauda D. Gemcitabine and carboplatin combination chemotherapy in treatment naive patients with inoperable gall bladder cancer. Eur J Cancer. 2016;54:S9.
• Singh S, Goel V, Talwar V, Raina S, Mitra S, Saxena U, Shekhon R, Rawal S. Neo-adjuvant chemotherapy followed by surgery versus definitive chemo radiation as treatment for localized carcinoma cervix. Asian J Oncol. 2016;2(S01):022.
• Talwar V, Raina S, Goel V, Doval DC. Gemcitabine and cisplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer: a study from Northern India cancer institute. Int J Hepatobiliary Pancreat Dis. 2016;6:108-113.
• Prashant V, Singh S, Talwar V, Goyal P, Upadhyay A. Ovary: oral abstract. Asian J Oncol. 2016;2:1.
• Talwar V, Raina S, Goel V, Doval DC. Gemcitabine and carboplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer-A study from Northern Indian Cancer Institute. Br J Med Med Res. 2017;19(12):1-7.
• Raina S, Goel V, Talwaar V, et al. Soft palate metastasis: a rare site of metastasis in TCC of urinary bladder. JMS SKIMS. 2017;20(1):47-48.
• Goel V, Jain A, Tiwari S, John MC, Talwar V, Dash P, et al. Randomised prospective study of maintenance tamoxifen versus post adjuvant chemotherapy surveillance only in advanced ovarian cancer patients. Ann Oncol. 2017;28:v339.
• Venkata PPB, Talwar V, Goel V, Prasantha K, Bajaj R, Sharma M, Medisetty P, Ram D, Agrawal C, et al. Unusual tree bark-like skin pigmentation over veins after 5-fluorouracil infusion with spontaneous resolution. Human Journals. 2017;7(3).
• Jajodia A, Koyyala VPB, Goel V, Dash PK, Rajappa SK, Amrith BP. Pancreatic giant cell tumor: a variant of pancreatic adenocarcinoma with aggressive course. Asian J Oncol. 2018;4:79-80.
• Goel V, Tiwari S, Talwar V, Pattnaik N, Dash P, Raina S, John MC. 56P plasma circulating ctDNA: potential biomarker in non-small cell lung carcinoma and clinical significance. J Thorac Oncol. 2018;13(4):S29.
• Venkata PPB, Talwar V, Raina S, Goel V, Dash PK, Bajaj R, Sharma M, Medisetty P, Ram D, Agrawal C, et al. Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: a study from North India Cancer Centre. Indian J Cancer. 2018;55(3):222-225.
• Talwar V, Bothra SJ, Goel V, Dash PK, Jajodia A, Domadia K, Choudhary K, Koyyala VPB. Real world outcomes of checkpoint inhibitors immunotherapy in renal and urothelial cancers in a tertiary care cancer center in India. Int J Mol Immuno Oncol. 2019;4(3):63-66.
• Talwar V, Goel V, Dash P. Cancer-related fatigue in carcinoma urinary bladder patients receiving chemotherapy: a single institutional study from northern India. American Society of Clinical Oncology; 2019.
• Dash PK, Koyyala VPB, Suryavanshi M, Jajodia A, Pasricha S, Goel V, Bothra SJ, Goyal S, Batra U, Doval DC. Adoption of molecular testing in breast cancer in a tertiary care center in a developing country. Ann Oncol. 2019;30:ix127.
• Goswami V, Koyyala VPB, Goyal S, Sharma M, Goel V, Dhamne N, Maheshwari U, Sharma A. Efficacy of PARP inhibitors in the treatment of ovarian cancer: a literature-based review. Asian J Oncol. 2019;5(1):1-18.
• Agrawal CR, Sharma M, Talwar V, Goel V, Singh AP. Isolated splenic recurrence of treated jejunal cancer: a case report with brief review of literature. Indian J Med Paediatr Oncol. 2019;40(S01):S163-S165.
• Amrith BP, Koyyala VPB, Dash PK, Goel V, Bansal D, Talwar V. A rare cause of headache in common cancer: ovarian carcinoma with brain metastasis. Indian J Gynecol Oncol. 2019;17:1-4.
• Talwar V, Raina S, Goel V, Dash P, Doval DC. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer. Indian J Med Res. 2020;152(5):475-481.
• Chaudhari KA, Talwar V, Goel V, Dash PK, Bothra S, Domadia K, Koyyala VPB. A rare malignancy at the gastrojejunostomy stump. Cancer Res Stat Treat. 2020;3(2):312-316.
• Goyal P, Maheshwari U, Jain P, Agrawal C, Chaudhari KA, Goyal S, Batra U, Bothra S, Goel V, Talwar V, et al. Rectal cancer in young patients: clinicoepidemiologic profile and treatment outcomes. American Society of Clinical Oncology; 2020.
• Koyyala VPB, Jajodia A, Beer L, Doval DC, Talwar V, Goel V, Batra U, Goyal S, Gupta A, Chaturvedi A, et al. 215P analysis of spatial heterogeneity of responses in metastatic sites with nivolumab in renal cell carcinoma. Ann Oncol. 2020;31:S1324.
• Basnet B, Goyal P, Mahawar V, Bothra SJ, Agrawal C, Thapa BB, Talwar V, Jain P, Koyyala VPB, Goel V, et al. Role of 18F-flurodeoxyglucose positron-emission tomography/computed tomography in the evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer. Indian J Nucl Med. 2020;35(2):105-109.
• Koyyala VPB, Goyal S, Jajodia A, Goel V, Amrith BP, Soni S, Doval DC. Miliary brain metastasis-a rare pattern of metastases from breast cancer. South Asian J Cancer. 2020;9(03):188-189.
• Sharma M, Talwar V, Maheshwari U, Koyyala VPB, Goel V, Goyal S, Dash PK, Batra U, Bajaj R, Yadav A, et al. Role of maintenance gemcitabine in advanced carcinoma gallbladder. South Asian J Cancer. 2020;9(04):204-208.
• Maheshwari U, Rajappa SK, Talwar V, Goel V, Dash PK, Sharma M, et al. Adjuvant chemotherapy in uterine carcinosarcoma: comparison of a doublet and a triplet chemotherapeutic regimen. Indian J Cancer. 2021;58(2):179-184.
• Goyal P, Doval DC, Agarwal C, Jain P, Chaudhari K, Domadia K, Redhu P, Koyyala VPB, Goel V, Batra U, et al. Current treatment approaches for human epidermal growth factor receptor 2-positive breast cancer in adjuvant and neoadjuvant settings. Indian J Med Paediatr Oncol. 2021;42(01):35-45.
• Goel V, Jain P, Goyal P, Patnaik N, Pasricha S, Koyyala V, Talwar V. P-48 Study of paclitaxel and ramucirumab as second-line therapy after failure of FOLFOX-6 regimen in metastatic stomach carcinoma patients. Ann Oncol. 2021;32:S112.
• Goel V, Patnaik N, Talwar V, Chaudhari K, Koyyala V, Goyal P. P-194 Study of efficacy and safety of combination of octreotide acetate LAR with lenvatinib as second-line therapy in patients with advanced G1-G2 NETs of non-pancreatic origin. Ann Oncol. 2021;32:S166.
• Goel V, Patnaik N, Koyyala VPB, Talwar V, Chowdhary K, Jain P, Goyal P, Raina S. 1447P efficacy and toxicity profile of trans dermal buprenorphine for cancer pain management: experience from a tertiary care center in northern India. Ann Oncol. 2021;32:S1078.
• Talwar V, Patnaik N, Goyal P, Doval DC, Goel V. Study of efficacy and toxicity profile of gemcitabine and erlotinib based chemotherapy regimen in locally advanced (inoperable) and metastatic carcinoma pancreas. Eur J Mol Clin Med. 2021;8(4):949-958.
• Koyyala VPB, Kulkarni PS, Goel V, Goteti SC, Purohit SR, Jajodia A, et al. 67P Challenges to molecular testing for selecting targeted therapies for oncology patients in India. Ann Oncol. 2021;32:S1366.
• Koyyala VPB, Sharma M, Goyal P, Goel V, Bommera S, Agrawal M, et al. Epidemiological, clinical profile, and treatment outcome of stage IV nonsquamous nonsmall cell lung cancer patients presenting to tertiary care hospital in North India. Oncol J India. 2021;5(3):104-110.
• Koyyala VPB, Chandra S, Goel V, Pasricha S, Gupta M, Muppalla BS, et al. 76P Need for awareness about immune-related adverse events (iRAEs) among community physicians in India. Ann Oncol. 2021;32:S1405.
• Joga S, Bansal A, Talwar V, Bothra SJ, Dash P, Goel V, Koyyala VPB. Spontaneous pulmonary arterial embolization: a rare complication of the silicon-based peripherally inserted central venous catheter (PICC). J Vasc Access. 2022;23(3):471-473.
• Dogra A, Talwar V, Goel V, Sekhon R, Rawal S. First-line chemotherapy analysis on survival in carcinoma ovary patients: data from a Northern Indian cancer center. J Cancer Res Ther. 2022;18(6):1589-1596.
• Domadia K, Goel V, Koyyala VPB, Patnaik N, Chaudhari K, Raina S, Doval DC, Talwar V. Study of gemcitabine plus nab-paclitaxel-based chemotherapy regimen as first-line treatment in metastatic pancreatic carcinoma. South Asian J Cancer. 2022;11(01):031-035.
• Jajodia A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola M. Combined diagnostic accuracy of diffusion and perfusion MR imaging to differentiate radiation-induced necrosis from recurrence in glioblastoma. Diagnostics. 2022;12(3):718.
• Agarwal H, Talwar V, Anand S, Goel V, Patnaik N. Psychological challenges encountered by health care professionals having a risk of accidental exposure and its impact on their wellbeing in a non-Covid hospital during the prevailing pandemic. Int J Health Sci. 2022;5(S3):816-822.
• Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, et al. Corelation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World J Clin Oncol. 2022;13(5):339-351.
• Maheshwari U, Sharma M, Goel V, Goyal P, Jain P, Agarwal C, et al. Clinical profile and outcomes of treatment in gastric cancer in young patients in India. Asian J Oncol. 2022;8(03):111-118.
• Casolino R, Braconi C, Prete MG, Romero FG, Castro RE, Banales JM, et al. Bridging the equity gap in patient education: the biliary tract cancer BABEL project. Lancet Oncol. 2022;23(5):568-570.
• Jajodia A, Goel V, Patnaik N, Pasricha S, Gupta G, Batra U, Talwar V. Analysis of spatial heterogeneity of responses in metastatic sites in renal cell carcinoma patients treated with nivolumab. Tomography. 2022;8:1363-1373.
• Patnaik N, Pasricha S, Gupta G, Durga G, Sharma SK, Sharma A, et al. EBV positive diffuse large B-cell lymphoma, NOS in a patient of Crohn's disease treated with immunomodulator. Indian J Pathol Microbiol. 2022;65(3):739-741.
• Narayan S, Talwar V, Redhu P, Goel V, Jain A, Soni S, et al. Serpentine supra-venous hyperpigmentation 'Badge of Courage' in fight against cancer: a brief review. Gulf J Oncol. 2022;1(40):83-87.
• Amrith BP, Goel V, Joga S, Koyyala VPB, Goyal S, Batra U, Doval DC, Talwar V. 122P Efficacy and safety of mFOLFOX-6 in advanced gastric cancer: a prospective observational study. Ann Oncol. 2022;33:S1480.
• Jajodia A, Goel V, Goyal J, Patnaik N, Khoda J, Pasricha S, Gairola M. Combined diagnostic accuracy of diffusion and perfusion MR imaging to differentiate radiation-induced necrosis from recurrence in glioblastoma. Diagnostics. 2022;12:718.
• Aggarwal A, Goel S, Sayed AI, Goel V, Talwar V, Singh S. Interaortocaval lymph node metastasis in gall bladder cancer: is it regional node or metastatic disease? J Gastrointest Cancer. 2023;54(4):1252-1260.